Skip to content
GENIUS-CHD
GENIUS-CHD
Genetics of Subsequent Coronary Heart Disease
  • GENIUS-CHD
  • About
    • What is GENIUS-CHD?
    • Background & Rationale
  • Member Cohorts
  • Organisation
    • Scientific Steering Committee
    • Operational Committee
    • Project Specific Working Groups
  • Join Us
  • News
  • Documents
  • Contact

Organisation

The activity of GENIUS-CHD is coordinated via steering committees and working groups:

  • Operational Committee (OC)
  • Scientific Steering Committee (SSC)
  • Project Specific Working Groups (PSWG)
  • Administrative & Statistical Groups

 

 

Contact us via email: genius.consortium@gmail.com

RSS Latest Articles on Subsequent CAD Risk Research

  • Pharmacogenetic and clinical predictors of response to clopidogrel plus aspirin after acute coronary syndrome in Egyptians.
    Related Articles Pharmacogenetic and clinical predictors of response to clopidogrel plus aspirin after acute coronary syndrome in Egyptians. Pharmacogenet Genomics. 2018 09;28(9):207-213 Authors: Fathy S, Shahin MH, Langaee T, Khalil BM, Saleh A, Sabry NA, Schaalan MF, El Wakeel LL, Cavallari LH Abstract OBJECTIVES: Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel reduces the risk […]
Copyright © 2019 GENIUS-CHD — Stout WordPress theme by GoDaddy